Cargando…

Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537]

Detalles Bibliográficos
Autores principales: Mirza, Muhammad Usman, Saadabadi, Atefeh, Vanmeert, Michiel, Salo-Ahen, Outi M.H., Abdullah, Iskandar, Claes, Sandra, De Jonghe, Steven, Schols, Dominique, Ahmad, Sarfraz, Froeyen, Matheus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417583/
https://www.ncbi.nlm.nih.gov/pubmed/33814256
http://dx.doi.org/10.1016/j.ejps.2021.105827
_version_ 1783748406312697856
author Mirza, Muhammad Usman
Saadabadi, Atefeh
Vanmeert, Michiel
Salo-Ahen, Outi M.H.
Abdullah, Iskandar
Claes, Sandra
De Jonghe, Steven
Schols, Dominique
Ahmad, Sarfraz
Froeyen, Matheus
author_facet Mirza, Muhammad Usman
Saadabadi, Atefeh
Vanmeert, Michiel
Salo-Ahen, Outi M.H.
Abdullah, Iskandar
Claes, Sandra
De Jonghe, Steven
Schols, Dominique
Ahmad, Sarfraz
Froeyen, Matheus
author_sort Mirza, Muhammad Usman
collection PubMed
description
format Online
Article
Text
id pubmed-8417583
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-84175832021-09-07 Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537] Mirza, Muhammad Usman Saadabadi, Atefeh Vanmeert, Michiel Salo-Ahen, Outi M.H. Abdullah, Iskandar Claes, Sandra De Jonghe, Steven Schols, Dominique Ahmad, Sarfraz Froeyen, Matheus Eur J Pharm Sci Corrigendum Elsevier B.V. 2021-07-01 2021-04-01 /pmc/articles/PMC8417583/ /pubmed/33814256 http://dx.doi.org/10.1016/j.ejps.2021.105827 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Corrigendum
Mirza, Muhammad Usman
Saadabadi, Atefeh
Vanmeert, Michiel
Salo-Ahen, Outi M.H.
Abdullah, Iskandar
Claes, Sandra
De Jonghe, Steven
Schols, Dominique
Ahmad, Sarfraz
Froeyen, Matheus
Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537]
title Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537]
title_full Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537]
title_fullStr Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537]
title_full_unstemmed Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537]
title_short Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537]
title_sort corrigendum to ‘discovery of hiv entry inhibitors via a hybrid cxcr4 and ccr5 receptor pharmacophore-based virtual screening approach’ [european journal of pharmaceutical sciences 155 (2020) 105537]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417583/
https://www.ncbi.nlm.nih.gov/pubmed/33814256
http://dx.doi.org/10.1016/j.ejps.2021.105827
work_keys_str_mv AT mirzamuhammadusman corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537
AT saadabadiatefeh corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537
AT vanmeertmichiel corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537
AT saloahenoutimh corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537
AT abdullahiskandar corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537
AT claessandra corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537
AT dejonghesteven corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537
AT scholsdominique corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537
AT ahmadsarfraz corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537
AT froeyenmatheus corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537